Globus Medical GMED
NYSE GMED
$85.66 -2.68 (-3.03%)
As of: Aug 20, 2026 · 3:59 PM EDT

Globus Medical (GMED) Gross Profit (2011 - 2026)

Globus Medical's (GMED) quarterly Gross Profit came in at $525.8 million in Q1 2026, up 30.56% YoY from $402.7 million in Q1 2025, and down 6.99% on a QoQ basis from $565.3 million in Q4 2025.

Globus Medical (GMED) Gross Profit (2011 - 2026) Analysis & Trends

Globus Medical (GMED) has 16 years of Gross Profit data on file, last reported at $525.8 million in Q1 2026.

  • Quarterly Gross Profit rose 30.56% year-over-year to $525.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 billion (up 38.3% YoY) and the FY2025 annual result came in at $2.0 billion, up 33.51% from the prior year.
  • Gross Profit fell to $525.8 million in Q1 2026, from $565.3 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $565.3 million in Q4 2025 to a low of $171.4 million in Q1 2022.
  • A 5-year average of $339.4 million and a median of $355.2 million in 2024 frame the typical range for Gross Profit.
  • Annual changes were most pronounced in 2022 — Gross Profit declined 0.54% — and 2024, when it soared 77.39%.
  • Tracing GMED's Gross Profit over 5 years: stood at $203.9 million in 2022, then soared by 72.16% to $351.0 million in 2023, then rose by 12.19% to $393.9 million in 2024, then jumped by 43.53% to $565.3 million in 2025, then retreated by 6.99% to $525.8 million in 2026.
  • The last three Gross Profit figures came in at $525.8 million (Q1 2026), $565.3 million (Q4 2025), and $516.5 million (Q3 2025), per Business Quant data.

Peer Comparison

Historic Data

Download Data
DateValue